Monthly Archives: October 2022

Gene Therapy Is Here To Stay: Should Bigger Companies Build, Buy, Or Partner?
October 13, 2022

By Deanna Petersen, CBO of AVROBio, as part of the From the Trenches feature of LifeSciVC Gene therapy’s tremendous potential to transform the treatment of both rare and common diseases has been understood for decades. But few may appreciate how

Leave a comment

Mind Meld: How Intellectually Diverse Teams Can Drive Resilience And Better Outcomes  
October 7, 2022

By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC Biotechnology, especially of late, requires us to prevail over adversity to deliver for patients.  Spero, dedicated to new solutions for patients with infections,

Leave a comment

Breaking Up Is Hard To Do – But It Doesn’t Have To Be!
October 4, 2022

By Your Friendly Neighborhood Biotech CEO, as part of the From The Trenches feature of LifeSciVC (… an Anonymous CEO) As one thinks about the iconic break-up lines, it doesn’t take long to come up with: It’s not you; it’s

Leave a comment